GABA3 is the major inhibitory neurotransmitter in the mammalian central nervous system (1). It mediates its effects via both ionotropic (GABA A ) and metabotropic (GABA B ) receptors. GABA C receptors are a subfamily of GABA A receptors and are sometimes referred to as GABA receptors, because the first subunit identified from this class of receptor was called 1 (2). These receptors have been separated from "classic" GABA A receptors because of their distinct pharmacological properties;GABA C receptor-mediated responses are not inhibited by bicuculline (the classic competitive GABA A receptor antagonist) nor induced by baclofen (the classic GABA B receptor agonist). In addition, 3-aminopropylphosphinic acid, a potent competitive GABA C receptor antagonist, acts as an agonist at the GABA B receptor and is inactive at the GABA A receptor, and GABA and trans-4-aminocrotonic acid are more potent agonists at GABA C receptors than GABA A or GABA B receptors (3). Thus there is clearly some variation in the structures of the different GABA-binding sites contained in these receptors, although the sequence homology between GABA A and GABA C receptor subunit sequences (Ͼ25%) indicates that their basic structures will be similar (structural homology is estimated at close to 80%) and will be similar to other members of the Cys loop family (4, 5).The lack of detailed structural information available for Cys loop receptors means that homology modeling is currently one of the best approaches to investigate possible molecular interactions between binding site residues and ligands. This approach has been made possible by the availability of the high resolution structure of the acetylcholine binding protein (AChBP), which is homologous to the extracellular domain of the nicotinic ACh receptor (6). Using this as a template, computer-generated models of ligandbinding pockets of Cys loop receptors, combined with previous data from structure-activity studies, have identified important features of these pockets and on the orientation of agonists and antagonists when located in their binding sites (7)(8)(9)(10)(11)(12)(13). Generating an accurate representation of the orientation of GABA in the GABA C receptor-binding site could identify the processes involved in ligand recognition at this receptor and would also assist in drug design; current data indicate that drugs acting on GABA C receptors could possibly be used to treat visual, sleep, and cognitive disorders (4,14).It has recently been shown that Tyr-198 forms a cationinteraction with the positive amine of GABA (15), and thus we can confidently locate this part of the GABA molecule close to this residue. The aim of this study was to locate the other end of GABA, the carboxylate group, in the binding site. This negatively charged end of GABA has been shown to interact with one or more positively charged residues in the GABA A receptor-binding pocket (16), and here we examine the role of positively charged and polar residues that are in or close to GABA in the GABA C receptor-binding...